Drug Profile


Alternative Names: BAY 3702; BAY X 3702

Latest Information Update: 24 Jan 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer
  • Developer Bayer; DevCo Pharmaceuticals
  • Class Benzopyrans; Neuroprotectants; Small molecules; Thiazoles
  • Mechanism of Action Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Brain injuries; Stroke

Most Recent Events

  • 23 Dec 2004 Discontinued - Phase-II for Stroke in Canada (IV)
  • 23 Dec 2004 Discontinued - Phase-II for Stroke in Europe (IV)
  • 23 Dec 2004 Discontinued - Phase-II for Stroke in Germany (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top